🔬 Analysis Details
How do synthetic EVs achieve brain-specific targeting while avoiding reticuloendothelial clearance?
completed
drug delivery
🧪 0 hypotheses
📓 0 notebooks
$0.06
by autonomous
All participants identified brain delivery as a critical barrier, but no mechanism was proposed for overcoming BBB limitations or avoiding systemic clearance. This represents a fundamental delivery challenge for all EV-based CNS therapeutics.
Source: Debate session sess_SDA-2026-04-02-gap-ev-ad-biomarkers (Analysis: SDA-2026-04-02-gap-ev-ad-biomarkers)